A therapeutic perspective for proliferative vitreoretinopathy based on the inhibition of epithelial-mesenchymal transition by miR-194

Ann Transl Med. 2020 Apr;8(8):525. doi: 10.21037/atm.2020.03.181.
No abstract available

Publication types

  • Editorial
  • Comment